What You Should Know:
- Wondr Health, a leader in virtual metabolic health programs, has announced the expansion of its weight and obesity care solution, Wondr Plus.
- The enhancement provides comprehensive lifestyle support and nutrition counseling for employees using GLP-1 weight-loss medications, addressing the challenges of medication adherence and side effects.
Addressing the Need for GLP-1 Support
While GLP-1 medications have shown promising results for weight loss,
Read More
Thoughtful AI Launches AI Agents to Optimize Revenue Cycle Management
What You Should Know:
- Thoughtful AI, an innovator in AI-powered revenue cycle transformation, has announced the launch of its comprehensive team of specialized AI Agents for revenue cycle management (RCM).
- By optimizing back-office operations and reducing delays in billing, approvals, and claims processing, Thoughtful AI enhances the patient experience. This leads to faster access to care, fewer billing errors, and improved transparency regarding out-of-pocket
Read More
GeneDx Launches Tool to Fuel Rare Disease Drug Discovery
What You Should Know:
- GeneDx, a leader in genomic insights, has announced the launch of GeneDx Discover, a groundbreaking data visualization tool designed to revolutionize drug discovery and development.
- The platform provides biopharmaceutical companies with access to de-identified and aggregated genetic data, empowering them to accelerate the development of new therapies.
Addressing the Challenges of Drug Development
The traditional drug development process is
Read More
Synapticure Raises $25M to Expand Virtual Care for Neurodegenerative Diseases
What You Should Know:
- Synapticure, a virtual care company focused on neurodegenerative diseases secures $25M in a Series A funding round led by B Capital, the investment includes participation from new investors CommonSpirit Health, CVS Health Ventures, RA Capital Management, and Nexus NeuroTech Ventures, as well as existing investors Google Ventures, Optum Ventures, and Rock Health Capital.
- Founded by individuals with firsthand experience navigating the challenges of
Read More
DexCom and ŌURA Partner to Optimize Metabolic Health Tracking
What You Should Know:
- DexCom, the global leader in continuous glucose monitoring (CGM), and ŌURA, the maker of the leading smart ring, have announced a strategic partnership to help millions of people improve their metabolic health.
- The collaboration will integrate Dexcom's glucose data with ŌURA's comprehensive health metrics, providing users with a more holistic view of their well-being.
A Holistic Approach to Metabolic Health
By combining Dexcom's CGM data with
Read More
Jimini Health Launches with $8M for AI Therapist Assistant, Sage
What You Should Know:
- Jimini Health, a digital health company reimagining mental healthcare, has announced its launch with $8 million in pre-seed funding from Zetta Venture Partners, LionBird, PsyMed, BoxGroup, Arkitekt Ventures, SCB, and others.
- The company offers a unique, clinician-led therapy model enhanced by responsible AI, aiming to improve patient outcomes and transform the mental health experience.
- Jimini Health was co-founded by Luis Voloch, Mark Jacobstein,
Read More
The Clinic by Cleveland Clinic Appoints Dr. David Peter as Chief Medical Officer
What You Should Know:
- The Clinic by Cleveland Clinic, a provider of virtual second opinions (VSOs), has appointed Dr. David Peter as its new Chief Medical Officer (CMO).
- Dr. Peter brings a wealth of experience in clinical excellence, executive leadership, and care transformation to this role, where he will guide The Clinic's continued growth and expansion of high-quality specialty care access across the United States.
Dr. Peter Bio/Background
Dr. Peter most recently
Read More
Owkin, Proscia Partner to Streamline MSI Testing for Colorectal Cancer
What You Should Know:
- Owkin, an AI-biotech company specializing in precision medicine, and Proscia, a leader in AI-enabled pathology solutions, have announced a strategic partnership to improve MSI testing for colorectal cancer (CRC). This collaboration aims to enhance the efficiency and accessibility of MSI screening, ultimately leading to better patient outcomes.
- Beyond MSI testing, Owkin and Proscia plan to collaborate on developing and commercializing additional AI solutions
Read More
Lunit, AstraZeneca Partner to Develop AI-Powered Pathology Tools for Faster Lung Cancer Diagnostics
What You Should Know:
- Lunit, a provider of AI solutions for cancer diagnostics and therapeutics, has announced a strategic collaboration with AstraZeneca, a global pharmaceutical company, to develop AI-powered digital pathology solutions.
- The partnership aims to improve cancer treatment by leveraging AI to analyze tissue samples and predict the likelihood of specific genetic mutations.
Focusing on Lung Cancer Treatment with AI
The collaboration will initially focus on
Read More
NVIDIA BioNeMo Framework Accelerates AI Drug Discovery
What You Should Know:
- NVIDIA announced widespread adoption of its open-source BioNeMo™ Framework by pharmaceutical companies, techbio innovators, and AI researchers to accelerate drug discovery and molecule design.
- The framework provides a powerful suite of tools for scaling AI models in biomolecular research, bringing supercomputing capabilities to the forefront of drug development.
Accelerating Drug Discovery with AI
The BioNeMo Framework addresses the growing need
Read More
